Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA)
Regular ArticleProstanoid receptors in intestinal epithelium: selective expression, function, and change with inflammation☆
References (29)
- et al.
Role of prostaglandins in ulcerative colitis: enhanced production during active disease and inhibition by sulfasalazine
Gastro
(1978) - et al.
Incidence rates of ulcerative colitis and Crohn's disease in fifteen areas of the United States
Gastroenterology
(1981) - et al.
Structural analysis of a human intestinal epithelial cell line
Gastroenterology
(1987) - et al.
Prostaglandin synthesis inhibitors in ulcerative colitis: flubiprofen compared with conventional therapy
Prostaglandins
(1981) - et al.
Benoxaprophen in the treatment of ulcerative colitis
Prost Leuko Med
(1983) - et al.
Mechanism of chloride secretion induced by carbachol in a colonic epithelia cell line
J Clin Invest
(1986) - et al.
IL-1 stimulates intestinal myofibroblast COX gene expression
Am J Physiol
(1996) - et al.
Prostaglandin-mediated effects on growth and markers of biochemical development in the rat
Ped Research
(1983) - et al.
Effect of the prostaglandin analogue misoprostol on cell proliferation in the canine small intestine
Emp Physiol
(1991) - et al.
Classification of prostanoid receptors: properties, distribution and structure of the receptors and their subtypes
Pharmacol Rev
(1994)
Regulation by prostaglandin E2of interleukin release by T lymphocytes in mucosa
J Cell Physiol
Rectal mucosal prostaglandin E2release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis
Gut
Mucosal synthesis and release of PGE2from activated eosinophils and macrophages in ulcerative colits
Am J Gastro
Pathology of ulcerative colitis
Cited by (47)
Targeting beta-catenin signaling for prevention of colorectal cancer – Nutraceutical, drug, and dietary options
2023, European Journal of PharmacologyPARP14 regulates EP4 receptor expression in human colon cancer HCA-7 cells
2022, Biochemical and Biophysical Research CommunicationsProstaglandin E<inf>2</inf> receptors and their role in gastrointestinal motility – Potential therapeutic targets
2021, Prostaglandins and Other Lipid Mediators15-Keto-PGE<inf>2</inf> acts as a biased/partial agonist to terminate PGE<inf>2</inf>-evoked signaling
2020, Journal of Biological ChemistryProstaglandin E2 as a therapeutic target in bladder cancer: From basic science to clinical trials
2020, Prostaglandins and Other Lipid MediatorsCitation Excerpt :As the focus of this review is on cancer, we will focus on EP2 and EP4, which are the most commonly cited EP receptors mediating pro-tumorigenic effects [11]. Canonically, EP2 and EP4 are both G-protein coupled receptors that can initiate signaling through adenylate cyclase, cyclic AMP and protein kinase A mediated activation of transcription factors such as cAMP response element-binding protein (CREB) [36,37]. EP2 and EP4 also have been reported to activate PI3K and ß-catenin pathways to resulting in upregulation of transcription factors controlling a variety of pro-tumorigenic functions including cellular proliferation, cellular stemness, cellular invasion and angiogenesis in cancer cells [34,35].
- ☆
Grant support: Supported in part by a grant from NCl, National Institute of Health (CA68226) and by the Crohn's and Colitis Foundation of America.
- f1
Correspondence to: James K. Roche, MD, PhD, Box 1005, MR-4 Building, UVA Health Sciences Center, Charlottesville, VA 22908, USA. Tel.: +804 243 2655; Fax: +804 243 6169; E-mail: [email protected]